InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
Discover the full record of transactions filed by Huhn Stephen L.. Officer active across 1 company, notably Contineum Therapeutics, Inc.. In total, 1 filings have been published. Activity tracked since 13 August 2024. The latest transaction was disclosed on 13 August 2024 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
1 of 1 declaration